Robotic Assisted Laparoscopic Radical Prostatectomy: Perioperative Outcomes Of 1500 Consecutive RALPs
September 23, 2007 – 8:21 pm | posted in ProstateUroToday.com - Presented Wednesday, 05 September 2007 at the 29th Congress of the Societe International d’Urologie - SIU 2007 - Optimizing Clinical Outcomes in Prostate and Renal Cell Carcinomas - The Second Annual Symposium on Advanced GU Malignancy - Palais des Congres de Paris, France
Introduction: There has been an increasing demand for the use of robotic assisted laparoscopic radical prostatectomy (RALP) in the last 5 years for the treatment of prostate cancer. We report the perioperative outcomes of 1500 consecutive RALPs performed by a single surgeon (VRP) over a 53 month period.
Methods: Using a six port, transperitoneal approach, 1500 consecutive patients underwent RALP. Data recollected included quality of life questionnaires (EPIC, SHIM, AUA), age, height, weight, body mass index (BMI); prostate specific antigen (PSA), clinical stage and Gleason grade. Perioperative outcome measures included: operative time (OR), estimated blood loss (EBL), prostate size, length of hospital stay, pathology and time of catheter removal.
Results: Mean OR was 105 minutes and EBL was 111ml with no transfusions or mortalities. Ninety seven percent of patients were discharged on postoperative day, one with a mean catheter time of 6.3 days (range 4 28). Positive margin rate was 4% for T2 tumors, 34% for T3, 40% for T4 tumors and an overall of 11.6% for the entire series.
Conclusions: RALP is a safe and feasible procedure for the treatment of prostate cancer.
Authors: Palmer KJ, Shah K, Thaly R, Patel V
UroToday - the only urology website with original content written by global urology key opinion leaders actively engaged in clinical practice.
To access the latest urology news releases from UroToday, go to: www.urotoday.com

You must be logged in to post a comment.